The Hartford Insurance Group, Inc. (HIG), better known simply as The Hartford, is one of the largest U.S. property and casualty (P&C) insurers and a major provider of group benefits. The stock, not an ETF, has spent recent months trading between roughly $120 and $146. The question for investors is whether shares can climb to $155, a level that appears in public market discussion but sits well above the broad analyst consensus.
HIG carries a broadly constructive but unenthusiastic Street view. Across roughly two dozen analysts tracked by S&P Global, the consensus rating is a "Buy" or "Moderate Buy," yet the average price target sits near $146.86 — a figure implying only about 7% upside from the latest price. Because that average is already so close to the current quote, it does not provide a meaningful basis for a "Can it reach?" analysis.
The $155 central target instead reflects the more bullish end of public discussion. A cluster of recent above-consensus objectives — including Wells Fargo at $158, J.P. Morgan at $157, Goldman Sachs at $152, and RBC Capital at $150 — frames a $150–$160 zone that a favorable earnings cycle could justify. At the same time, cautious voices such as Morgan Stanley ($135), KBW ($137), and Truist ($137) sit near or below the current price, underscoring how divided the Street is. This $155 figure is a reasonable midpoint of that bullish discussion, not an official consensus.
HIG recently traded near $136.76, toward the upper end of its 52-week range of $120.33 to $146.07. Reaching $155 would require about a 13% advance — a substantial move for a low-beta insurance name. The stock trades at roughly 9.4 times trailing earnings (P/E, price-to-earnings ratio) and about 10 times forward EPS (earnings per share), with a return on equity near 22% and a dividend yield around 1.75%. Getting to $155 would likely require both earnings delivery and a modest re-rating of that multiple.
The Hartford's second-quarter 2026 results were strong: revenue of about $7.26 billion and net income near $1.3 billion, up from roughly $6.99 billion and $995 million a year earlier. The completed acquisition of Equitable's employee-benefits business adds about $500 million in premium and strengthens group benefits, while a $1.12 billion reinsurance commutation is expected to add roughly $393–$497 million to third-quarter net income. Share buybacks, a growing dividend, and higher interest rates that lift investment income provide additional underpinnings.
The sector faces real headwinds. Industry forecasts point to a P&C combined ratio deteriorating toward roughly 99% in 2026, and analysts flag commercial-casualty loss trends, personal-insurance growth, and normalizing underwriting margins. Mizuho downgraded the stock to Neutral in September, and several firms trimmed targets ahead of earnings. The company also announced that A. Morris "Mo" Tooker will succeed Christopher Swift as CEO effective March 2027, adding a transition-related overhang. A multiple de-rating has already been a meaningful drag on the shares this year.
The stock's 52-week high near $146.07 is the first meaningful resistance level, followed by the round-number $150 mark and the $155 objective itself. Support sits around the 200-day moving average near $135 and the 50-day average near $133, with the 52-week low at $120.33 providing a deeper floor. A durable push above $146–$147 would be a notable change in the stock's technical character.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms differ. Investors should watch third-quarter earnings released in late October 2026, management's guidance and commentary on pricing and loss trends, the pace of buybacks, Federal Reserve rate decisions, and any further analyst revisions. The CEO transition and integration of the Equitable benefits business are longer-dated items that could shape sentiment.
AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Traders can use the tool to uncover opportunities, track existing positions, and spot changing trends more efficiently than manual screening allows. For those following HIG and similar names, the signals offer a useful complement to fundamental research.
The $155 target is an ambitious but not unreasonable objective derived from the more bullish end of public analyst discussion, not from the broad consensus, which averages closer to $147. Reaching it would require a roughly 13% advance supported by continued underwriting discipline, sustained investment income, and a re-rating toward higher multiples. Working against that are sector margin pressure, cautious downgrades, and the upcoming leadership transition. With the stock near its 52-week high and earnings on deck, the path to $155 depends on execution rather than a simple re-rating.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HIG has been closely correlated with TRV. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIG jumps, then TRV could also see price increases.
| Ticker / NAME | Correlation To HIG | 1D Price Change % |
|---|---|---|
| HIG | 100% | +2.36% |
| HIG (16 stocks) | 76% Closely correlated | +2.51% |
| Multi-Line Insurance (12 stocks) | 74% Closely correlated | +2.96% |